The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
about
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trialsArrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 geneTreatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statementTreatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus StatementArrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular diseaseMechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathyArrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.Predictors of appropriate ICD therapy in patients with arrhythmogenic right ventricular cardiomyopathy: long term experience of a tertiary care center.Risk stratification in arrhythmogenic right ventricular cardiomyopathy.[Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies].Gender Difference in Idiopathic Right Ventricular Outflow Tract-Ventricular TachycardiaPrimary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy.Diagnosis of arrhythmogenic right ventricular cardiomyopathyArrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature ReviewEmbodying a New Meaning of Being At Risk: Living With an Implantable Cardioverter Defibrillator for Arrhythmogenic Right Ventricular Cardiomyopathy.Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature.Sex differences in cardiomyopathies.Pharmacotherapy and other therapeutic modalities for managing Arrhythmogenic Right Ventricular Cardiomyopathy.Is gene discovery research or diagnosis?Risk stratification for sudden death in arrhythmogenic right ventricular cardiomyopathy.Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).Precision medicine approach to genetic cardiomyopathy.Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy.Perceived economic burden associated with an inherited cardiac condition: a qualitative inquiry with families affected by arrhythmogenic right ventricular cardiomyopathy.Genomics, haplotypes and cardiovascular disease.Failure of ICD therapy in lethal arrhythmogenic right ventricular cardiomyopathy type 5 caused by the TMEM43 p.Ser358Leu mutation.Sudden cardiac death in young athletes.'It had to be done': genetic testing decisions for arrhythmogenic right ventricular cardiomyopathy.Gender differences in implantable cardioverter-defibrillator patients at the time of insertion.Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.The Curious Case of the De-ICD: Negotiating the Dynamics of Autonomy and Paternalism in Complex Clinical Relationships.Right ventricular dysplasia: management and treatment in light of current evidence.The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43Translation of research discoveries to clinical care in arrhythmogenic right ventricular cardiomyopathy in Newfoundland and Labrador: Lessons for health policy in genetic disease
P2860
Q24650348-1447D803-7962-4A48-A314-38AE48500265Q24656100-C9161A9C-B7A6-48B0-AF99-E4CE887CF41EQ26799094-5E10F977-891B-417C-969F-4D20219E6194Q26799143-24EA759D-0F5B-4D0B-8C47-61256CDA9EB1Q27024037-0332154D-B72A-4790-BC37-38ECCCB392B6Q28274829-73491F80-424B-470E-9D08-85D0BF29E7F0Q33159766-9249AA81-C05D-49E1-B9AC-E9EA360357E7Q33161842-F3A80033-78AF-4BB0-BF1D-6DC5C6550A3CQ33163382-B8689CFB-1568-4781-8829-0C33BDB70766Q33165762-E6649251-44B1-4106-BE2F-DE8BBC6E98C7Q33167101-67F3E5AB-1556-426B-A38F-31D558DBF3BFQ36247394-A94CE87F-4AA6-4B84-A051-EF1FE1205408Q36251940-B53D8587-BB1B-45FE-9B01-5440C73BD57BQ36426852-5A8E7CCF-E4B4-4B11-9E44-3584668F7E5DQ36887235-50BB95D9-C85E-4DA0-87BF-4B26E48C4B63Q37689201-9A57A0E1-E443-48BA-8CF4-0E7CDA06744AQ37994613-BC8AD269-7B78-4188-BFFA-FE5AB86E0B2AQ38182007-4BF75219-7D32-4758-AFE7-E29B950DF3E3Q38430205-6904F0D2-9FEA-4B0D-B570-5198310B98C8Q38442473-C4E87BBD-A333-4057-B5AD-3EC3C1C6F2EFQ38462951-8D783D46-820D-4326-BD99-F6CB971DE489Q38639575-4D7612E2-073D-46C0-95C4-8FAA181D63DEQ38666336-EDECEF1C-9BD7-44B6-B3E1-8358D6D87C8DQ38928152-F45BA033-35E5-4BC6-BA99-8AAA0D440594Q38948638-DA37A206-1F31-4CBF-8D7F-85B42663EFCAQ40159300-B6DF5045-20D8-4401-9517-058ED74EDBCEQ41826265-4A1D797B-2C7B-47D7-AD8D-FAC7BB887CB9Q42173761-609FC528-12F1-43CD-9A5B-3380F09FF264Q48064393-3AC6BAC2-A51F-4311-B8ED-3B333449B408Q48497911-6A2CAE7C-44D8-4FFD-ADAC-29C2AF2FC1C4Q48726319-695CE162-06D7-4CD8-95B8-68C06519EA03Q51273111-77E8F6E9-568F-42AE-8629-0C5680BA0B39Q55286785-D2F7E3B5-CBF7-400E-BEE5-76826BE4AC77Q57901761-E3BC552C-F684-43EA-83BB-444A652F59CCQ58069140-83EE7C25-4CF8-4977-8FE8-A1D96DC1A541
P2860
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The impact of implantable card ...... ricular cardiomyopathy (ARVD5)
@ast
The impact of implantable card ...... ricular cardiomyopathy (ARVD5)
@en
type
label
The impact of implantable card ...... ricular cardiomyopathy (ARVD5)
@ast
The impact of implantable card ...... ricular cardiomyopathy (ARVD5)
@en
prefLabel
The impact of implantable card ...... ricular cardiomyopathy (ARVD5)
@ast
The impact of implantable card ...... ricular cardiomyopathy (ARVD5)
@en
P2093
P2860
P1476
The impact of implantable card ...... ricular cardiomyopathy (ARVD5)
@en
P2093
Anne S Bassett
Christine Kupprion
Elizabeth L Dicks
Kathy A Hodgkinson
Ludwig Thierfelder
Mark W Norman
Patrick S Parfrey
Sean P Connors
Susan N Stuckless
William J McKenna
P2860
P304
P356
10.1016/J.JACC.2004.08.068
P407
P577
2005-02-01T00:00:00Z